What medications can I take for levator scapulae and upper trapezius myofascial pain?

Medications for Levator Scapulae and Upper Trapezius Myofascial Pain

First-Line Pharmacologic Treatment

NSAIDs are the recommended first-line medication for myofascial pain affecting the levator scapulae and upper trapezius muscles. 1, 2

• Start with either naproxen 500 mg twice daily or ibuprofen 600-800 mg three times daily to target the inflammatory component of muscle pain 3
• Celecoxib may be considered if gastrointestinal risk factors are present, though no NSAID has proven superior to others for musculoskeletal pain relief 2
• Topical NSAIDs can be considered for localized pain to minimize systemic effects, particularly in patients over 75 years 1
• NSAIDs should be used with caution in patients with cardiovascular disease, renal insufficiency, heart failure, or peptic ulcer disease risk 1

Second-Line: Muscle Relaxant Therapy

If NSAIDs alone provide insufficient relief, add tizanidine as the preferred muscle relaxant based on superior evidence quality. 3

Tizanidine Dosing Algorithm

• Start with 2 mg up to three times daily, particularly if you are older or at higher risk for adverse effects 3
• Titrate upward as needed based on response and tolerability 3
• Limit treatment duration to 7-14 days maximum for acute myofascial pain 3
• Monitor for hypotension, sedation (most common dose-related effects), and hepatotoxicity (generally reversible) 3

Combination Therapy Benefits

• Adding tizanidine to an NSAID provides consistently greater short-term pain relief than NSAID monotherapy 3
• The combination increases CNS adverse events 2.44-fold but reduces gastrointestinal adverse events to 0.54-fold compared to NSAID alone, resulting in an acceptable overall safety profile 3

Medications to AVOID

Do NOT use the following medications for peripheral myofascial pain:

• Gabapentin and pregabalin are ineffective for peripheral musculoskeletal tightness, as they target neuropathic pain mechanisms rather than myofascial pain 3
• Baclofen is inappropriate unless muscle spasm is attributable to CNS pathology (multiple sclerosis, spinal cord injury); it lacks evidence for peripheral musculoskeletal pain and commonly causes muscle weakness that worsens functional impairment 3
• Benzodiazepines should be avoided due to no proven benefit for musculoskeletal pain and high risks of abuse and falls 3
• Systemic corticosteroids are not recommended for myofascial pain, as they provide no clinically significant benefit 3
• Opioids should be avoided for myofascial pain; use only the lowest dose possible if absolutely necessary and reevaluate regularly 1

Evidence Quality Considerations

The recommendation for tizanidine over other muscle relaxants is based on 8 high-quality trials demonstrating efficacy in acute low back pain, compared to only 1 lower-quality trial for cyclobenzaprine and sparse evidence (2 trials) for baclofen 3. Recent comprehensive reviews confirm that NSAIDs and local anesthetic injections have sufficient evidence for myofascial pain syndrome, while muscle relaxants, antidepressants, and other systemic medications show insufficient or inconclusive evidence 4, 5.

Critical Safety Warnings

• All skeletal muscle relaxants increase CNS adverse events 2-fold compared to placebo, with drowsiness being the most common side effect 3
• Time-limited courses are essential due to limited evidence on long-term benefits and risks 3
• NSAIDs require assessment of cardiovascular, gastrointestinal, and renal risk factors before prescribing 2
• Most NSAID trials for musculoskeletal pain were only 2 weeks in duration, making long-term benefit-risk assessment difficult 2

Adjunctive Non-Pharmacologic Approaches

While you asked specifically about medications, nonpharmacologic therapies such as physical therapy, massage, myofascial release, and trigger point injections with local anesthetics are more effective than systemic medications for myofascial pain and should be pursued concurrently 1, 4, 5. Trigger point injections have sufficient evidence supporting their use, while dry needling, acupuncture, and manual therapy show some evidence of effectiveness 4.